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Data from the rapid mortality surveillance system in 
19 major Italian cities were used to carry out a timely 
assessment of the health impact of the COVID-19 epi-
demic. By 18 April, a + 45% excess in mortality was 
observed, with a higher impact in the north of the 
country (+ 76%). The excess was greatest among men, 
with an increasing trend by age. Surveillance data 
can be used to evaluate the lockdown and re-opening 
phases.
Italy has been one of the countries worst hit by coro-
navirus disease (COVID-19), with over 185,000 cases 
and around 80% registered in north of the country [1]. 
Numbers in the initial phase of the outbreak in Italy 
seem to suggest a greater severity of the disease, 
with a higher case fatality rate (CFR) than previously 
observed in China (7.2% vs 2.3%) [2].
The aim of the study was to estimate the excess in total 
mortality by age and sex during the epidemic in Italian 
cities.
The rapid mortality surveillance system in 
Italy
Since 2004, Italy has had a rapid mortality surveillance 
system (SiSMG) for real-time monitoring of daily deaths 
in major Italian cities and allows routine evaluation of 
the health impact of extreme events and influenza 
epidemics [3,4]. This surveillance system was a valu-
able tool for an early evaluation of the direct or indi-
rect impact of COVID-19 on health. It is a standardised 
surveillance system capable of detecting variations in 
total mortality in the entire population rather than only 
on the infected cases, and it does not depend on a 
specific case definition (i.e. COVID-19-related deaths).
Briefly, SiSMG is based on an ad hoc daily flow of mor-
tality data (resident population by age and sex) from 
local Municipal Registry Offices to the Department of 
Epidemiology, Lazio Regional Health Authority - ASL 
Roma 1 (DEPLAZIO) which manages the system on 
behalf of the Ministry of Health [5,6]. The standard-
ised methodology to evaluate excess mortality typi-
cally used in the Italian national surveillance system 
was considered when estimating the excess related to 
COVID-19 [3,5-7]. Specifically, the excess was defined 
as the difference between observed and baseline 
daily mortality (mean daily value by week and day of 
the week in the past 5 years). In this report, we show 
results for a subgroup of 19 cities, representative of 
almost all Italian regions, with timely updates of data, 
corresponding to 9 million residents (14% of the Italian 
population).
Excess total mortality during the 
coronavirus disease epidemic
Figure 1  shows the weekly trend in observed and 
expected (baseline) mortality in northern vs central 
and southern cities of Italy included in SiSMG. Shaded 
areas represent the confidence bands calculated as the 
estimated baseline +/− 1.96 × standard deviation of 
the series of observed deaths contributing to the base-
line. From the first week of March, a steep rise in mor-
tality was observed in cities in northern Italy (Figure 1). 
From the start of the COVID-19 epidemic until 18 April, 
an overall 4,805 (+ 45%) excess deaths were observed 
in Italian cities, with a significantly higher excess in cit-
ies in the north (+ 76%, +4,295 deaths) compared with 
the centre and south (+ 10%, + 510 deaths).
City-specific mortality data showed the highest excess 
in the cities in the north, especially Brescia (+ 197%) 
and Milan (+ 103%), Lombardy, Genoa, Liguria (+ 84%), 
Turin, Piedmont (+ 57%), Verona, Veneto (+ 40%) and 
Bologna and Emilia-Romagna (+ 47%). In contrast, the 
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south and central cities recorded a more contained 
(+ 7% in Rome, + 20% in Messina) or no excess.
Figure 2 shows excess mortality by sex and age groups 
among cities in the north and in the centre and south 
of Italy caused by the COVID-19 outbreak up until 3 
April 2020. Overall, the excess in mortality was higher 
among men than among women in cities in the north 
vs the centre and south of Italy (men:+ 87% and + 70% 
and women: + 17% and + 9%, respectively), with an 
increasing trend by age. The greatest excess in the 
north was among elderly men (+ 76% in 65–74 year-
olds, + 89% in 75–84 year-olds and + 102% in those 
85 years and older). In central and southern Italy, the 
excess in mortality among men was lower, with a sta-
tistically significant excess only among elderly men: 
+ 13% and + 28%, respectively, in the 75–84 years and 
≥ 85 years age group.
Discussion
Our results confirm that the epidemic had the strong-
est impact in the most affected areas of the North. 
National COVID-19 data show that the Lombardy region 
alone accounted for 40% of cases in Italy, followed by 
the neighbouring regions of Emilia-Romagna (12%), 
Piedmont (12%) and Veneto (9%) [1]. It should be con-
sidered that these four northern regions accounted 
for ca 70% of national trade and economic activity 
[8], which could have accelerated and amplified the 
spread of infection to and within this area of Italy. The 
regions of central and southern Italy registered nearly 
a week’s delay in the outbreak and cases are to date 
much lower, with ca 20% of total cases [1]. Central-
southern cities were comparatively less affected, pos-
sibly because containment measures were put in place 
before the emergency stage was reached.
Figure 1
Weekly trend in mean daily observed and expected mortality in northerna and central-southernb cities during the 
COVID-19 outbreak, Italy, November 2019–April 2020
A. North
60
120
180
240
300
2019 2020
M
ea
n 
da
ily
 m
or
ta
lit
y
M
ea
n 
da
ily
 m
or
ta
lit
y
Mortality Baseline 95% CI
B. Centre and South
60
120
180
240
300
30
 O
ct
 −
 5
 N
ov
6 
− 
12
 N
ov
13
 −
 19
 N
ov
20
 −
 2
6 
No
v
27
 N
ov
 −
 3
 D
ec
4 
− 
10
 D
ec
11
 −
 17
 D
ec
18
 −
 2
4 
De
c
25
 −
 3
1 D
ec
1 −
 7
 Ja
n
8 
− 
14
 Ja
n
15
 −
 2
1 J
an
22
 −
 2
8 
Ja
n
29
 Ja
n 
− 
4 
Fe
b
5 
− 
11
 F
eb
12
 −
 18
 F
eb
19
 −
 2
5 
Fe
b
26
 F
eb
 −
 3
 M
ar
4 
− 
10
 M
ar
11
 −
 17
 M
ar
18
 −
 2
4 
M
ar
25
 −
 3
1 M
ar
1 −
 7
 A
pr
8−
14
 A
pr
15
 −
 2
1 A
pr
22
 −
 2
8 
Ap
r
30
 O
ct
 −
 5
 N
ov
6 
− 
12
 N
ov
13
 −
 19
 N
ov
20
 −
 2
6 
No
v
27
 N
ov
 −
 3
 D
ec
4 
− 
10
 D
ec
11
 −
 17
 D
ec
18
 −
 2
4 
De
c
25
 −
 3
1 D
ec
1 −
 7
 Ja
n
8 
− 
14
 Ja
n
15
 −
 2
1 J
an
22
 −
 2
8 
Ja
n
29
 Ja
n 
− 
4 
Fe
b
5 
− 
11
 F
eb
12
 −
 18
 F
eb
19
 −
 2
5 
Fe
b
26
 F
eb
 −
 3
 M
ar
4 
− 
10
 M
ar
11
 −
 17
 M
ar
18
 −
 2
4 
M
ar
25
 −
 3
1 M
ar
1 −
 7
 A
pr
8−
14
 A
pr
15
 −
 2
1 A
pr
22
 −
 2
8 
Ap
r
2019 2020
CI: confidence interval; COVID-19: coronavirus disease; SiSMG: Italian rapid mortality surveillance system.
a North (Aosta, Bolzano, Turin, Milan, Brescia, Verona, Venice, Trieste, Trento, Genoa, Bologna).
b Centre and south (Perugia, Civitavecchia, Rome, Frosinone, Bari, Potenza, Palermo, Messina).
Black line: observed mortality; dashed line: expected mortality; pink shading: 95% CI.
Data source: SiSMG surveillance system, Ministry of Health Italy. Originally published in [6].
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When considering the impact of COVID-19 mortality, 
we should take into account the low mortality of the 
2019/20 winter, below the baseline from October to 
the end of February, which was attributable to the mild 
intensity of the influenza season and a warmer than 
average temperatures as shown in the latest SiSMG 
report [7]. This phenomenon of lower mortality may 
have led to a greater number of vulnerable individuals 
exposed to the COVID-19 epidemic, thus amplifying the 
impact on mortality in our country.
Prevalence of chronic diseases is an important risk fac-
tor to take into account when analysing excess mortal-
ity related to COVID-19. Previous studies have shown 
that both disease severity and death risk are higher 
in patients with co-existing illnesses [9,10]. Recent 
data from Italy show that ca 60% of COVID-19 deaths 
occurred in people with three or more comorbidities, 
mainly hypertension (69%), type-2 diabetes (32%), 
chronic renal failure (21%) and ischaemic heart disease 
(27%) [11]. In Italian cities, the higher mortality impact 
in men confirmed findings from a previous study in 
Italy [2]. Furthermore, experimental studies suggest 
that men are more susceptible to respiratory viral infec-
tions because of hormonal and epigenetic mechanisms 
involving innate immunity [12]. This has also been 
shown in animal studies for severe acute respiratory 
syndrome (SARS) coronavirus [13]. Another potential 
risk factor reported in the literature is smoking. Firstly, 
smoking is detrimental to the immune system and its 
responsiveness to infections and, specifically, it is able 
to upregulate the ACE-2 receptors in the airways, the 
key for SARS-CoV-2 virus entrance into the epithelial 
cells [10]. A recent review showed that smoking is most 
Figure 2
Excess mortality by sex and age groups (all ages, 15–64, 65–74, 75–84, ≥ 85 years) in northerna vs central and southernb 
cities, COVID-19 outbreak, Italy, starting datec–18 April 2020
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COVID-19: coronavirus disease; SiSMG: Italian rapid mortality surveillance system.
a North (Aosta, Bolzano, Turin, Milan, Brescia, Verona, Venice, Trieste, Trento, Genoa, Bologna).
b Centre and south (Perugia, Civitavecchia, Rome, Frosinone, Bari, Potenza, Palermo, Messina).
c Starting dates: Palermo, Turin, Venice: 25 February; Brescia: 26 February; Bari: 27 February; Bologna, Civitavecchia, Rome: 29 February; 
Genoa, Perugia, Trieste, Verona: 1 March; Potenza, Trento: 3 March; Frosinone: 4 March; Aosta: 5 March; Messina: 7 March [1].
Data source: SiSMG surveillance system, Ministry of Health Italy [5,6].
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probably associated with a negative progression and 
adverse outcomes of COVID-19 [10,14]. The higher prev-
alence of male smokers for all ages in Italy, especially 
among the elderly [15], may explain their higher predis-
position to COVID-19.
Furthermore, the potential role of air pollution has 
been as a possible factor influencing COVID-19 trans-
mission and an effect modifier of the number of cases 
[16,17]. Populations with a chronic exposure to high 
levels of air pollution, such as in the north of Italy [18], 
may have a greater predisposition to develop respira-
tory symptoms, which may make them more suscepti-
ble to COVID-19. However, evidence on the direct and 
indirect role of air pollution is to date limited and the 
causal pathways and the differential risk attributable 
to this in different geographical areas need to be fur-
ther investigated.
Considering our findings in the European context, the 
latest EuroMOMO bulletin shows a steep increase in 
excess all-cause mortality in several European coun-
tries, mostly in the age groups ≥ 65 and 15–64 years 
[19]. A comparison of official COVID-19 deaths in Europe 
and the United States suggests that adults younger 
than 65 years had a lower death risk than elderly peo-
ple, with high geographical variability, and that more 
than 99% of deaths occurred among people with previ-
ous illnesses [20]. The different risk factors associated 
with COVID-19 predisposition and severity need to be 
taken into account when assessing the geographical 
heterogeneity in the risk of COVID-19-related deaths in 
the different population subgroups.
Since the beginning of the Italian epidemic, efforts 
have been made to estimate the impact, which could 
possibly be greater than indicated by official data [1] 
because of a delay in death ascertainment and lack of 
specificity of COVID-19-related deaths. Despite these 
methodological challenges, rapid surveillance systems 
can help provide timely updates of the overall impact 
at population level and reference data for evaluation 
studies on lockdown measures during the epidemic. 
They can also help guide the re-opening phase in dif-
ferent areas.
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